Abstract
Most recommended obstetric therapeutic agents are not licensed for their purpose. There is a lack of funding for research and little development of new therapeutic agents for use in the treatment of pregnancy-related disorders. Current therapeutics used in maternal health and their licensing status are reviewed and suggestions for these shortfalls together with possible solutions considered.
| Original language | English |
|---|---|
| Pages (from-to) | 1707-1710 |
| Number of pages | 4 |
| Journal | Expert opinion on pharmacotherapy |
| Volume | 14 |
| Issue number | 13 |
| DOIs | |
| Publication status | Published - Sept 2013 |
Keywords
- Drug licensing
- Pregnancy
- Therapeutics
